We observed a borderline increased risk for HCC among carriers of combined CYP1A1*2A and SULT1A1 variant alleles as compared to the double wild-type homozygotes (OR = 1.67; 95% CI: 0.97–3.24) (Table 3). The gene discussed is SULT1A1; the disease is hepatocellular carcinoma.